Insider Transactions in Q2 2023 at Bellerophon Therapeutics, Inc. (BLPH)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 07
2023
|
Naseem Amin Director |
BUY
Grant, award, or other acquisition
|
Direct |
47,578
+14.02%
|
-
|
|
Jun 07
2023
|
Puissance Life Science Opportunities Fund Vi > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
134,421
-11.1%
|
$0
$0.83 P/Share
|
|
May 18
2023
|
Bobae Kim VP Reg. Affairs & Quality |
SELL
Open market or private sale
|
Direct |
9,455
-84.59%
|
$94,550
$10.0 P/Share
|
|
May 18
2023
|
Bobae Kim VP Reg. Affairs & Quality |
BUY
Exercise of conversion of derivative security
|
Direct |
1,288
+25.3%
|
$9,016
$7.43 P/Share
|
|
May 18
2023
|
Puissance Life Science Opportunities Fund Vi > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
560,000
-31.62%
|
$5,040,000
$9.46 P/Share
|